Blueprint Medicines CorpEquity-NMS: BPMC
Equity-NMS: BPMC
$97.43
-0.50
(2:30 pm IST)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$97.43
Open
$97.43
Today’s high
$97.98
Today’s low
$94.84
52W low
$68.28
52W high
$121.9
1Y
35.00%
5Y
5.00%
EPS (TTM)
-2.09
Shares O/S
63.53M
Market cap
6.12B
Insights
BPMC price is below its 200 day moving average
BPMC is in the highest 10% returns in the past year. It is a high momentum stock. High momentum stocks tend to outperform in the near term.
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Blueprint Medicines Corp

Blueprint Medicines Corporation is a global precision therapy company that is inventing life-changing medicines in two areas of allergy/inflammation and oncology/hematology. The Company delivers its approved medicines, including AYVAKIT/AYVAKYT (avapritinib) and GAVRETO (pralsetinib), to patients in the United States and Europe, and it is globally advancing multiple programs for systemic mastocytosis (SM), lung cancer, breast cancer and other genomically defined cancers, and cancer immunotherapy.

Its pipelines also include Elenestinib (BLU-263) (KIT), AYVAKIT (avapritinib) (KIT), Wild-type KIT research program, GAVRETO (pralsetinib) (RET), BLU-945 (EGFR), BLU-525 (EGFR), BLU-451 (EGFR exon 20 insertions), BLU-222 (CDK2), AYVAKIT (PDGFRA), GAVRETO (RET), BLU-222 (CDK2) and BLU-852 (MAP4K1). It is developing elenestinib (BLU-263), an investigational, orally available, potent and highly selective KIT inhibitor, for the treatment of indolent SM and other mast cell disorders. .


FAQs

Can I buy Blueprint Medicines Corp shares in India?
How to buy Blueprint Medicines Corp shares in India?
What is the share price of Blueprint Medicines Corp?
What is the Market Capitalization of Blueprint Medicines Corp?
What is the PE ratio of Blueprint Medicines Corp?
Is Blueprint Medicines Corp a good stock to buy?
In which sector / industry does Blueprint Medicines Corp operate?